Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, GA
Tardive Dyskinesia in Schizophrenic Patients
NeuroTrials Research is conducting a study to determine the effectiveness of an investigational drug on the involuntary repetitive body movements known as tardive dyskinesia in individuals with schizophrenia or schizoaffective disorder. Qualified participants receive all study-related care and study drug at no cost, and compensation is available for time and travel.
Call (404) 851-9934 or visit www.neurotrials.com
Patient Inclusion Criteria:
- You may qualify if you:
- are 18-65
- have a diagnosis of schizophrenia or schizoaffective disorder
- have a diagnosis of tardive dyskinesia
- are otherwise in good health
Patient Exclusion Criteria:
NeuroTrials Research, Inc.
1100 Johnson Ferry Road, Suite 420
Atlanta, GA 30342
Research Center Information: NeuroTrials Research, Inc.
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these